# US FDA approves Revolution Medicines targeted drug for metastatic pancreatic cancer

https://mins.news/en/item/33406

- CNN, 2026-08-26 16:59 UTC
- Health
- Original: https://www.cnn.com/2026/08/26/health/daraxonrasib-pancreatic-cancer-fda?Date=20260826&Profile=CNN

> The US Food and Drug Administration has approved a targeted drug from Revolution Medicines for adults with metastatic pancreatic cancer who have received prior treatment or cannot undergo combination chemotherapy.

## Related coverage

- [FDA approves Rasonque for advanced pancreatic cancer](https://mins.news/en/item/33694) — France 24, 2026-08-26
- [FDA approves groundbreaking new drug for pancreatic cancer](https://mins.news/en/video/33476) — NBC News, 2026-08-26
- [FDA Approves RevMed’s Breakthrough Pill for Pancreatic Cancer](https://mins.news/en/item/33323) — Bloomberg News, 2026-08-26